Davita Inc (NYSE:DVA) – Equities research analysts at Jefferies Group issued their FY2018 earnings per share (EPS) estimates for shares of Davita in a research note issued to investors on Thursday. Jefferies Group analyst K. Lee expects that the company will earn $3.97 per share for the year. Jefferies Group also issued estimates for Davita’s FY2019 earnings at $4.98 EPS.
DVA has been the topic of a number of other research reports. Raymond James Financial upgraded Davita from an “outperform” rating to a “strong-buy” rating and lifted their price objective for the stock from $65.00 to $84.00 in a research report on Thursday, December 7th. Royal Bank of Canada reduced their price objective on Davita from $64.00 to $60.00 and set a “sector perform” rating on the stock in a research report on Wednesday, November 8th. Bank of America upgraded Davita from a “neutral” rating to a “buy” rating and lifted their price objective for the stock from $75.00 to $85.00 in a research report on Thursday, January 4th. Robert W. Baird reiterated a “hold” rating and set a $63.00 price objective on shares of Davita in a research report on Friday, November 10th. Finally, KeyCorp reiterated a “hold” rating on shares of Davita in a research report on Monday, November 13th. Two investment analysts have rated the stock with a sell rating, five have issued a hold rating, four have issued a buy rating and two have given a strong buy rating to the company. Davita currently has an average rating of “Hold” and a consensus target price of $79.30.
Davita (NYSE:DVA) last issued its quarterly earnings results on Tuesday, February 13th. The company reported $0.92 earnings per share (EPS) for the quarter, missing the Zacks’ consensus estimate of $0.94 by ($0.02). The firm had revenue of $2.78 billion during the quarter, compared to analyst estimates of $3.90 billion. Davita had a return on equity of 12.86% and a net margin of 4.65%. During the same period in the prior year, the firm earned $0.98 earnings per share.
In other Davita news, insider James K. Hilger sold 5,608 shares of Davita stock in a transaction on Thursday, December 7th. The stock was sold at an average price of $69.46, for a total value of $389,531.68. Following the sale, the insider now owns 47,649 shares in the company, valued at $3,309,699.54. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, insider James K. Hilger sold 3,572 shares of Davita stock in a transaction on Tuesday, January 16th. The shares were sold at an average price of $78.95, for a total value of $282,009.40. Following the completion of the sale, the insider now owns 33,649 shares in the company, valued at approximately $2,656,588.55. The disclosure for this sale can be found here. Insiders sold 121,509 shares of company stock worth $8,310,388 in the last 90 days. Company insiders own 2.00% of the company’s stock.
A number of large investors have recently bought and sold shares of DVA. OppenheimerFunds Inc. raised its position in Davita by 5,292.6% in the fourth quarter. OppenheimerFunds Inc. now owns 1,873,918 shares of the company’s stock valued at $135,391,000 after purchasing an additional 1,839,168 shares during the period. Millennium Management LLC raised its position in Davita by 239.9% in the fourth quarter. Millennium Management LLC now owns 2,024,308 shares of the company’s stock valued at $146,256,000 after purchasing an additional 1,428,810 shares during the period. Bridger Management LLC purchased a new stake in Davita in the fourth quarter valued at $52,339,000. International Value Advisers LLC purchased a new stake in Davita in the fourth quarter valued at $45,175,000. Finally, Schroder Investment Management Group raised its position in Davita by 769.0% in the third quarter. Schroder Investment Management Group now owns 434,191 shares of the company’s stock valued at $25,387,000 after purchasing an additional 384,224 shares during the period. Institutional investors own 82.88% of the company’s stock.
Davita Company Profile
DaVita Inc, formerly DaVita HealthCare Partners Inc, operates two divisions: DaVita Kidney Care (Kidney Care) and DaVita Medical Group (DMG). The Kidney Care division consists of its the United States dialysis and related lab services, its ancillary services and strategic initiatives, including its international operations, and its corporate administrative support.
Receive News & Ratings for Davita Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Davita and related companies with MarketBeat.com's FREE daily email newsletter.